Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SEL1L |
| Upstream (Parents) |
|---|
| (<<) ANKRD12 → SEL1L |
| (<<) STARD8 → SEL1L |
| (<<) TMEM19 → SEL1L |
| (<<) ALAS2 → SEL1L |
| (<<) CEBPD → SEL1L |
| (<<) SIRT4 → SEL1L |
| (<<) CPT2 → SEL1L |
| (<<) CD97 → SEL1L |
| Downstream (Children) |
|---|
| SEL1L → ANKRD12 (>>) |
| SEL1L → PGLYRP1 (>>) |
| SEL1L → TMEM19 (>>) |
| SEL1L → BRF2 (>>) |
| SEL1L → ALAS2 (>>) |
| SEL1L → PDGFRA (>>) |
| SEL1L → LOC652346///PML (>>) |
| SEL1L → SCN8A (>>) |
| SEL1L → NSL1 (>>) |
| SEL1L → DNAJC28 (>>) |
| SEL1L → FKRP (>>) |
| SEL1L → SURF1 (>>) |
| SEL1L → GSTTP1 (>>) |
